Cipher Mining Valuation
Is CIFR * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CIFR * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CIFR * (MX$60) is trading below our estimate of fair value (MX$749.86)
Significantly Below Fair Value: CIFR * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CIFR *?
Other financial metrics that can be useful for relative valuation.
What is CIFR *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$1.38b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 8.1x |
Enterprise Value/EBITDA | 29.6x |
PEG Ratio | 1.7x |
Price to Earnings Ratio vs Peers
How does CIFR *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 51.8x | ||
ENGH Enghouse Systems | 22x | 11.3% | CA$1.8b |
MAPMYINDIA C. E. Info Systems | 85.5x | 27.0% | ₹117.6b |
DCBO Docebo | 77.9x | 34.0% | CA$1.8b |
TANLA Tanla Platforms | 21.6x | 15.1% | ₹119.8b |
CIFR * Cipher Mining | 83.1x | 50.1% | Mex$1.4b |
Price-To-Earnings vs Peers: CIFR * is expensive based on its Price-To-Earnings Ratio (83.1x) compared to the peer average (51.8x).
Price to Earnings Ratio vs Industry
How does CIFR *'s PE Ratio compare vs other companies in the Global Software Industry?
Price-To-Earnings vs Industry: CIFR * is expensive based on its Price-To-Earnings Ratio (83.1x) compared to the Global Software industry average (31.5x).
Price to Earnings Ratio vs Fair Ratio
What is CIFR *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 83.1x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CIFR *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$60.00 | Mex$145.51 +142.5% | 15.9% | Mex$176.61 | Mex$117.74 | n/a | 10 |
Sep ’25 | Mex$75.00 | Mex$150.19 +100.2% | 13.6% | Mex$173.99 | Mex$115.99 | n/a | 8 |
Aug ’25 | Mex$104.50 | Mex$125.02 +19.6% | 17.9% | Mex$163.58 | Mex$90.88 | n/a | 7 |
Jul ’25 | n/a | Mex$121.71 0% | 19.8% | Mex$166.39 | Mex$92.44 | n/a | 6 |
Jun ’25 | n/a | Mex$97.34 0% | 14.6% | Mex$125.15 | Mex$83.43 | n/a | 6 |
May ’25 | n/a | Mex$97.05 0% | 20.2% | Mex$137.01 | Mex$77.07 | n/a | 6 |
Apr ’25 | n/a | Mex$94.20 0% | 20.2% | Mex$132.99 | Mex$74.81 | n/a | 6 |
Mar ’25 | n/a | Mex$96.71 0% | 20.2% | Mex$136.53 | Mex$76.80 | n/a | 6 |
Feb ’25 | n/a | Mex$98.18 0% | 19.0% | Mex$134.65 | Mex$75.74 | n/a | 6 |
Jan ’25 | n/a | Mex$93.09 0% | 13.1% | Mex$107.24 | Mex$75.96 | n/a | 6 |
Dec ’24 | n/a | Mex$93.09 0% | 13.1% | Mex$107.24 | Mex$75.96 | n/a | 6 |
Nov ’24 | n/a | Mex$91.23 0% | 15.3% | Mex$109.47 | Mex$72.98 | n/a | 6 |
Oct ’24 | n/a | Mex$89.62 0% | 12.0% | Mex$102.42 | Mex$76.82 | n/a | 6 |
Sep ’24 | n/a | Mex$87.43 0% | 11.4% | Mex$102.86 | Mex$77.15 | Mex$75.00 | 5 |
Aug ’24 | n/a | Mex$75.99 0% | 24.3% | Mex$101.32 | Mex$50.66 | Mex$104.50 | 5 |
Jul ’24 | n/a | Mex$62.62 0% | 13.6% | Mex$69.58 | Mex$52.18 | n/a | 5 |
Jun ’24 | n/a | Mex$62.14 0% | 14.3% | Mex$71.02 | Mex$53.27 | n/a | 4 |
May ’24 | n/a | Mex$62.75 0% | 14.3% | Mex$71.71 | Mex$53.79 | n/a | 4 |
Apr ’24 | n/a | Mex$53.82 0% | 4.9% | Mex$55.67 | Mex$50.10 | n/a | 3 |
Mar ’24 | n/a | Mex$52.64 0% | 5.3% | Mex$55.41 | Mex$49.87 | n/a | 2 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.